Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:PS 16:0_17:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST003792 AN006233 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Maple syrup urinary disease University of Colorado Denver LC-MS
ST003792 AN006233 Untargeted lipidomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Metabolic disease University of Colorado Denver LC-MS
ST002505 AN004127 A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) Cultured cells Human Cancer University of Science and Technology of China LC-MS
ST001267 AN002104 Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism Tongue Human Cancer University of Helsinki MS(Dir. Inf.)
  logo